In briefBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3816 (Published 14 July 2015) Cite this as: BMJ 2015;351:h3816
Companies fined for supplying defective prefilled syringes: The company Fresenius Kabi has been fined £500 000 (€695 000; $775 000) plus £5900 in costs and Calea UK £50 000 with £5900 costs for supplying hospitals with defective prefilled syringes that contributed to the death of a patient with diabetes. Neil Judge developed multiorgan failure after being treated with a batch of intravenous insulin syringes that contained no insulin. The faulty syringes were supplied to Sheffield Teaching Hospitals NHS Foundation Trust by Fresenius Kabi as a licensed wholesaler for Calea UK, the manufacturer.
Breast cancer campaign targets older women: About a third of women who receive a diagnosis of breast cancer report a symptom other than a lump, says a campaign from Public Health England to increase the knowledge of lesser known symptoms among women over 70. Women should also look out for changes in the shape their breasts, the nipple, and the skin. Public Health England said that older women were more likely to delay going to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial